Literature DB >> 29770100

Lymphogranuloma venereum in Quebec: Re-emergence among men who have sex with men.

C A Boutin1, S Venne2, M Fiset2, C Fortin1,3, D Murphy3, A Severini4, C Martineau1,3, J Longtin3, A C Labbé1,3.   

Abstract

BACKGROUND: Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by Chlamydia trachomatis genotypes L1, L2 and L3. This LGV is associated with significant morbidity and increased risk of HIV transmission. While fewer than two cases per year were reported in Quebec before 2005, LGV emerged in 2005-2006 with 69 cases, followed by a period of low incidence (2007-2012), and subsequent re-emergence since 2013.
OBJECTIVES: To describe the incidence of LGV in Quebec and the characteristics of the affected population, including demographics and risk factors, clinical manifestations, laboratory tests, treatments and reinfection rates.
METHODS: Descriptive data were collected from the notifiable diseases records through the Institut national de santé publique du Québec (INSPQ) infocentre portal. Questionnaires were obtained through the enhanced surveillance system and transmitted anonymously to the Quebec Ministry of Health. In-depth analysis was performed on cases from 2013 to 2016.
RESULTS: There were 338 cases of LGV over the four-year period in Quebec. All cases were male, excluding one transsexual. Mean age was 41 years. Most lived in Montréal (81%) and were men who have sex with men (MSM; 99%). The majority (83%) reported four sexual partners or more in the last year, met mostly through the Internet (77%) and in saunas (73%). Frequency of sexual intercourse with out-of-province residents decreased in 2013-2016 (27%) compared with 2005-2012 (38%). History of STIs was frequent: 83% were HIV-infected, 81% reported previous syphilis and 78% previous gonorrhea. Recreational drug use was frequent (57%), reaching 71% in 2016. Most cases were symptomatic, a proportion which decreased in 2016 (68%) compared with 2013-2015 (82%; p=0.006). Clinical presentations included proctitis (86%), lymphadenopathy (13%) and ulcer/papule (12%). Reinfections, mostly within two years of first infection, occurred in 35 individuals (10%).
Conclusion: The re-emergence of LGV in Quebec involves an urban subpopulation composed almost exclusively of MSM with STIs, who have a high number of partners and often use drugs.

Entities:  

Year:  2018        PMID: 29770100      PMCID: PMC5864252          DOI: 10.14745/ccdr.v44i02a04

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  23 in total

1.  Rapid increase in lymphogranuloma venereum in men who have sex with men, United Kingdom, 2003 to September 2015.

Authors:  Tristan Childs; Ian Simms; Sarah Alexander; Kirstine Eastick; Gwenda Hughes; Nigel Field
Journal:  Euro Surveill       Date:  2015

2.  Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with men.

Authors:  N T Annan; A K Sullivan; A Nori; P Naydenova; S Alexander; A McKenna; B Azadian; S Mandalia; M Rossi; H Ward; N Nwokolo
Journal:  Sex Transm Infect       Date:  2009-01-28       Impact factor: 3.519

3.  Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, The Netherlands: trends over time, symptomatology and concurrent infections.

Authors:  Nynke Hesselina Neeltje de Vrieze; Martijn van Rooijen; Maarten Franciscus Schim van der Loeff; Henry John C de Vries
Journal:  Sex Transm Infect       Date:  2013-02-20       Impact factor: 3.519

4.  Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior.

Authors:  Henry J C de Vries; Akke K van der Bij; Johan S A Fennema; Colette Smit; Frank de Wolf; Maria Prins; Roel A Coutinho; Servaas A Morré
Journal:  Sex Transm Dis       Date:  2008-02       Impact factor: 2.830

5.  Clinical and epidemiological characterization of a lymphogranuloma venereum outbreak in Madrid, Spain: co-circulation of two variants.

Authors:  M Rodríguez-Domínguez; T Puerta; B Menéndez; J M González-Alba; C Rodríguez; T Hellín; M Vera; F J González-Sainz; P Clavo; M Villa; R Cantón; J Del Romero; J C Galán
Journal:  Clin Microbiol Infect       Date:  2013-06-04       Impact factor: 8.067

Review 6.  Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment.

Authors:  Bradley P Stoner; Stephanie E Cohen
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

7.  Clinical and epidemiological characterisation of lymphogranuloma venereum in southwest Spain, 2013-2015.

Authors:  Manuel Parra-Sánchez; Silvia García-Rey; Isabel Pueyo Rodríguez; Pompeyo Viciana Fernández; María José Torres Sánchez; José Carlos Palomares Folía
Journal:  Sex Transm Infect       Date:  2016-06-09       Impact factor: 3.519

8.  New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam.

Authors:  Joke Spaargaren; Han S A Fennema; Servaas A Morré; Henry J C de Vries; Roel A Coutinho
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

9.  The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.

Authors:  Minttu M Rönn; Helen Ward
Journal:  BMC Infect Dis       Date:  2011-03-18       Impact factor: 3.090

10.  The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study.

Authors:  H Ward; S Alexander; C Carder; G Dean; P French; D Ivens; C Ling; J Paul; W Tong; J White; C A Ison
Journal:  Sex Transm Infect       Date:  2009-02-15       Impact factor: 3.519

View more
  2 in total

1.  Lymphogranuloma venereum.

Authors:  Eric J Eckbo; Malcolm Hedgcock; Troy Grennan
Journal:  CMAJ       Date:  2021-12-13       Impact factor: 8.262

2. 

Authors:  Eric J Eckbo; Malcolm Hedgcock; Troy Grennan
Journal:  CMAJ       Date:  2022-02-14       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.